December 14, 2025
avatar-torie-bosch
First Opinion editor

This week, First Opinion published a piece I’ve long wanted: a first-person perspective from a pharmacist at a chain pharmacy. Having spent too much time lurking on the subreddit for pharmacists, I’ve been worried for the people behind the pharmacy counter. “[T]he impossible workload we’re given could one day lead to a mistake that could have been prevented,” Chris Eggeman, a pharmacist at a CVS in Rhode Island, writes. “I have worked at a retail pharmacy for more than 15 years, and it has never been more challenging to do my job safely.”

This type of personal essay is so important because it illustrates a part of the health care system that often goes overlooked. If you work an often-overlooked health care job and are interested in writing, email me.

First Opinion Podcast: On the podcast this week, I spoke with Jason Karlawish, the new STAT+ Neurotransmissions columnist. We talked about the ongoing revolution in dementia — and the challenges it brings. There’s just one more episode left this season!

Recommendation of the week: The Guardian has released “The Birth Keepers,” a six-episode podcast series on its investigation into the Free Birth Society, which advocates for women to avoid any formal medical assistance during pregnancy and birth. It’s deeply distressing — and compelling.



Adobe

Rise of anti-science rhetoric has fundamentally changed the relationship between doctors and patients

When clinicians are hesitant to even raise the topic of vaccination, we inch toward a public-health landscape shaped not by science, but by noise.

By Krutika Kuppalli


Finally, some good news in health care

Nurses are fed up with too many shifts and too few staff. They're joining unions to improve their working conditions and patient care.

By Theresa Brown


When a doctor can’t heal his friends

When a doctor lost two close friends to diseases that couldn’t be treated, he learned to see suffering, compassion, and empathy in new ways.

By Venktesh Ramnath


Sarah Silbiger/Getty Images/STAT

STAT+ | FDA drug center’s new acting director fits a pattern of risky, internal contradictions among agency leadership

The FDA is tightening evidence demands for some products while loosening them for others. Expert says growing contradictions reflect ideology, not science.

By Paul Knoepfler


We wrote the HHS review on treatment for minors with gender dysphoria. We hope our critics actually read our report

Authors of a new HHS report on medical treatment for kids and teens with gender dysphoria argue that their work aligns with growing international consensus.

By Evgenia Abbruzzese, Alex Byrne, Farr Curlin, Moti Gorin, Kristopher Kaliebe, Michael K. Laidlaw, Kathleen McDeavitt, Leor Sapir, and Yuan Zhang


Now is the time to launch mpox vaccine booster trials

It's unclear how long the two-dose Jynneos vaccine for mpox offers protection. With cases of mpox clade I in the U.S., we need answers.

By Joseph Osmundson and Miguel I. Paredes


STAT

The revolution in dementia care is just beginning

Jason Karlawish on how diagnostics and treatment for Alzheimer’s and other causes of dementia are changing completely.

By Torie Bosch


It’s past time to update the rules intended to slow the FDA’s revolving door

Current post-employment rules fail to prevent the appearance (and too often the reality) of regulatory capture, especially with the FDA.

By Lee Rosebush and Marc Wagner


Why comparing the U.S. vaccine schedule to European countries’ is a red herring

CDC vaccine advisory committee, Trump want to ‘align’ U.S. childhood vaccine schedule with other countries. That’s misguided, writes expert.

By Richard Hughes IV


Adobe

My continuous glucose monitor graphs my life — but misses the big picture

A continuous glucose monitor should be able to capture the reason behind an unusual reading.

By Mark E. Paull


I’m a CVS pharmacist. My retail pharmacy colleagues and I face a crisis

What happens when pharmacists are expected to perform at the same level while the workplace condition deteriorates?

By Chris Eggeman


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.